LAWSUIT – Can Maerck MARKET Keytruda?

This topic is empty.

Post

- September 10, 2014 at 11:43 am
- Quote
JerryfromFauq
Participant
Bristol-Myers Sues Merck of Patent Infringement on Keytruda
Zacks.com – 1 day ago Merck said the lawsuit was without merit and that the company was confident it wouldn't be prevented from marketing pembrolizumab. Similar patent litigation among the companies is under way in Europe.

Merck said in an August filing to the U.S. Securities and Exchange Commission that the Ono patent was invalid.

http://online.wsj.com/articles/bristol-myers-ono-suing-merck-over-cancer-drug-patent-1410101449

You must be logged in to reply to this topic.

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

LAWSUIT – Can Maerck MARKET Keytruda?

About the MRF Patient Forum

Popular Topics

LAWSUIT – Can Maerck MARKET Keytruda?

About the MRF Patient Forum

Popular Topics

Topic Tags